ISRCTN10400022进行中（未招募）4 期
inTernatiOnal alfaPuMp® cOhort STudy (TOPMOST)
试验速览
- 阶段
- 4 期
- 状态
- 进行中（未招募）
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. All patients implanted with an alfapump® system as per intended use
排除标准
- •1. Younger than 18 years
- •2. Pregnancy
- •3. Inability to operate the Smart Charger to recharge the alfapump®
- •4. Participating in another study in which the alfapump® is studied
研究者
相似试验
招募中
不适用
Predictors of Bleeding Evaluation in Adult Hematologic Patients with Bleeding TendenciesNL-OMON27868MUMC+300
招募中
2 期
Clinical trial to examine the effectiveness of AMPA-PET to identify epileptogenic focus in refractory epilepsy patientsJPRN-jRCT1080224511Tomoyuki Miyazaki (Coordinating Investigator)40
已完成
3 期
Clinical trial of â??AHPL/AYTOP/2014Aâ?? Gel in mouth ulcerCTRI/2017/04/008386Ari Healthcare Pvt Ltd
进行中（未招募）
1 期
The purpose of this study is to assess the good and bad effects (efficacy and safety) of apixaban compared with usual care anticoagulation in people with Atrial Fibrillation in whom an early cardioversion is planned.EUCTR2014-001231-36-DEBristol-Myers Squibb International Corporation1,500
进行中（未招募）
1 期
The purpose of this study is to assess the good and bad effects (efficacy and safety) of apixaban compared with usual care anticoagulation in people with Atrial Fibrillation in whom an early cardioversion is planned.on-Valvular Atrial Fibrillation in patients undergoing CardioversionMedDRA version: 19.0Level: PTClassification code 10003658Term: Atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersEUCTR2014-001231-36-BEBristol-Myers Squibb International Corporation1,500